The short version of RP-HPLC fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-04-06. Anything still debated is marked as such rather than presented as settled.
Identity and purity are normally checked by reversed-phase high-performance liquid chromatography, often coupled to mass spectrometry. The peptide absorbs in the ultraviolet region, and the copper complex also shows a broad visible absorption band that can be followed spectroscopically. Copper content is measured separately, for example by inductively coupled plasma mass spectrometry or atomic absorption spectroscopy, because the peptide assay alone does not confirm how much metal is bound. Purity figures therefore need a stated basis: peptide peak area, copper content, or both.
Aqueous GHK-Cu solutions are less stable than the dry powder. Light, dissolved oxygen and elevated temperature all accelerate loss of the intact complex, and the main observable changes are fading of the blue colour and the appearance of peptide fragments. Acidic conditions protonate the histidine imidazole and weaken copper binding, while strongly alkaline conditions promote hydrolysis of the peptide backbone. Because several degradation routes operate at once, a single shelf-life figure does not describe all storage conditions.
Solid material is typically kept as a lyophilised powder in a sealed, light-protected container at minus 20 degrees Celsius, with desiccant where humidity is high. Working solutions are often prepared fresh, aliquoted and frozen to avoid repeated freeze-thaw cycles. Glassware and buffers are checked for trace metal contamination, since other transition metals can displace copper. Records of lot number, reconstitution date and storage temperature help trace unexpected colour changes. Blue colour itself is not a reliable purity test, because partly degraded solutions can remain visibly coloured.
The compound was first isolated from human plasma by the biochemist Loren Pickart in 1973. Early work identified it as a factor that altered the behavior of cultured liver cells, and later studies linked it to connective tissue and wound-related processes. Reported plasma concentrations fall markedly between roughly age twenty and age sixty, a pattern that generated interest in copper peptide biology. Whether that decline has functional consequences remains an open question, because differences observed across age groups do not by themselves establish causation. Research interest later expanded into cosmetic and tissue-culture settings.
Mechanistic accounts focus on how the complex delivers copper and how the released peptide interacts with the extracellular matrix. Copper is an essential cofactor for lysyl oxidase and other enzymes involved in collagen and elastin cross-linking, and GHK is one of several peptides able to carry the metal. Reported effects include altered gene expression in fibroblasts and changes in matrix metalloproteinase activity, although many of these findings come from cell culture rather than whole organisms. The relative contribution of the peptide backbone, the copper ion, and downstream copper metabolism is not fully resolved.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-lysine and a copper(II) ion. The peptide sequence is conventionally written as Gly-His-Lys, abbreviated GHK. Copper binds through the imidazole nitrogen of histidine, the alpha-amino group, and a deprotonated amide nitrogen, producing a square-planar geometry. The complex carries a net positive charge near physiological pH and is intensely blue in aqueous solution. The metal-free peptide is often written simply as GHK, while the copper-bound form is written GHK-Cu.
| Property | Value | Notes |
|---|---|---|
| Powder storage | Minus 20 degrees Celsius, dry, dark | Desiccant used where humidity is high |
| Solution storage | Frozen, single-use aliquots | Repeated freeze-thaw cycles increase breakdown |
| Light sensitivity | Loss of intact complex under prolonged light | Amber or opaque containers reduce exposure |
| Copper assay | ICP-MS or atomic absorption spectroscopy | Reports total copper, not the fraction bound to peptide |
| Purity assay | Reversed-phase HPLC with UV or MS detection | States whether purity refers to peptide peaks or to metal content |
The compound was first isolated from human plasma in the 1970s by Loren Pickart, who later described copper-binding activity in liver and other tissues. Early reports focused on its presence in blood and its ability to carry copper between proteins. Commercial and cosmetic use of the term 'copper peptide' has since broadened, and labels rarely distinguish GHK-Cu from other copper-binding fragments. This naming overlap makes literature searching harder, because cosmetic ingredient lists, supplier catalogues and laboratory papers use different vocabularies for the same molecule.
GHK-Cu is the copper-binding complex formed by the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The free peptide is usually written as GHK, and the complex is written as GHK-Cu or Cu-GHK. The sequence was identified in human plasma and later detected in saliva and urine. Its name comes from the single-letter codes of glycine, histidine and lysine. The complex is widely described as a naturally occurring carrier of copper in blood rather than as a free peptide with its own hormonal role.
Stability depends on temperature, light exposure, moisture, and the presence of oxidizing or reducing agents. Solid material held dry and protected from light is generally more stable than aqueous solutions, which can undergo gradual degradation. Recommended storage in much of the literature is a freezer at around minus twenty degrees Celsius for long-term retention, with working aliquots kept cold and shielded from light. Repeated freeze-thaw cycles and alkaline pH are commonly noted as factors that accelerate loss of the intact complex, though exact degradation rates vary.
Analytical confirmation usually combines a separation method with a copper-specific measurement. Liquid chromatography or mass spectrometry establishes peptide identity and purity, while an elemental measurement quantifies the metal content. A frequent misconception is that any blue solution contains an intact copper peptide complex; color alone does not confirm structure, because free copper salts and degraded mixtures can also appear colored. Literature on efficacy is mixed, with in vitro findings often more dramatic than human evidence, and reviews note small sample sizes and short follow-up. Open questions include optimal concentration, skin penetration, and long-term effects.
Published work on GHK-Cu is dominated by in vitro experiments and small animal studies. Human trials tend to be short and small, with endpoints such as skin appearance rather than clinical outcomes. Review articles often summarize the same underlying laboratory findings, which can make the evidence base look broader than it is. Several basic questions remain open: the concentration of the intact complex in human tissue, the route by which it crosses the skin barrier, and whether effects seen in culture produce measurable changes in people.
Laboratory studies describe GHK-Cu as a source of copper that cells can take up, with reported effects on collagen, elastin, and glycosaminoglycan synthesis in cultured fibroblasts. The peptide also appears in wound-repair research, where it is linked to the activity of matrix metalloproteinases and their inhibitors. These observations come largely from cell and animal models. How directly the complex controls any single pathway in intact human skin remains an open question, and reported effects depend on concentration, vehicle, and exposure time.
The tripeptide was first isolated from a human plasma filtrate in 1973 during studies of tissue repair factors. Later work detected the free peptide and its copper complex in saliva, urine, and wound fluid, suggesting a natural role in tissue remodeling. Plasma concentrations reported in early literature decline with age, a pattern often cited in discussions of skin aging. Whether these endogenous levels are directly functional or largely incidental remains an open question. The peptide sequence is conserved across mammalian species.
Material described in research and cosmetic supply chains is typically a synthetic peptide supplied as a lyophilized powder. Purity is commonly reported through chromatographic separation, often at 95 percent or higher, while copper content is confirmed by separate elemental analysis. Batch variation in color and solubility can reflect residual counter-ions, moisture, or partial oxidation of the peptide. Because the complex is not a single regulatory entity, specifications differ between suppliers and are not standardized internationally.
== Therapeutic use == As a mast cell activator, the MCD peptide evokes large increases in antigen-specific serum immunoglobulin G (IgG) responses. Therefore, it is used as a vaccine adjuvant. MCD peptide analogs, such as [Ala12] MCD, provide a base for designing agents that can prevent IgE/Fc-RIa interactions and reduce allergic conditions.
=== Bioremediation === Some yeasts can find potential application in the field of bioremediation. One such yeast, Yarrowia lipolytica, is known to degrade palm oil mill effluent, TNT (an explosive material), and other hydrocarbons, such as alkanes, fatty acids, fats and oils. It can also tolerate high concentrations of salt and heavy metals, and is being investigated for its potential as a heavy metal biosorbent. Saccharomyces cerevisiae has potential to bioremediate toxic pollutants like arsenic from industrial effluent. Bronze statues are known to be degraded by certain species of yeast. Different yeasts from Brazilian gold mines bioaccumulate free and complexed silver ions.
== Personal life == Kidder became a United States citizen on August 17, 2005, in Butte, Montana, and settled in Livingston. She said that she decided to become an American citizen to participate in the voting process, to continue her protests against U.S. intervention in Iraq, and to be free of worries about being deported.
==== Killing of Israeli civilians ==== The elimination of the State of Israel has been a primary goal for Hezbollah. Hezbollah has been accused of "only [regarding] the Jews living in Israel as Zionists, who should be killed". Throughout the war Hezbollah announced the targeting of civilian homes. On 12 November 2023, Hezbollah fired an anti-tank missile killing an employee of the Israel Electric Corporation who was conducting repair work and injured 13 other Israelis, including six other employees of the Israeli Electric Corporation. The most notable of Hezbollah's attacks on civilians was on 27 July 2024 in the Majdal Shams attack, when Hezbollah fired an Iranian-made Falaq-1 rocket at Majdal Shams, a Druze town in the Golan Heights. The rocket hit a football pitch killing 12 Druze children and injuring at least 42 others. Another attack by Hezbollah resulted in civilian casualties on 9 July 2024, when a rocket struck a couple's car just south of their hometown of Ortal. Additionally, a couple walking their dog in Kiryat Shmona was killed by shrapnel from a Hezbollah rocket on 9 October 2024. On 26 December 2023, a Hezbollah anti-tank missile impacted near a Channel 13 News team while they were interviewing a farmer at Dovev for an article following a prior Hezbollah assault that killed a 56-year-old employee of the Israel Electric Corporation, and injured five workers who were repairing electric lines. Throughout the conflict, Hezbollah fired thousands of inaccurate munitions at Israel and the Golan Heights, killing and injuring civilians and destroying houses.
Sources: en.wikipedia.org
== Pharmaceutical variants == The recombinant human G-CSF (rhG-CSF) synthesised in an E. coli expression system is called filgrastim. The structure of filgrastim differs slightly from the structure of the natural glycoprotein. Most published studies have used filgrastim. The Food and Drugs Administration (FDA) first approved filgrastim on February 20, 1991, marketed by Amgen with the brand name Neupogen. It was initially approved to reduce the risk of infection in patients with non-myeloid malignancies who are taking myelosuppressive anti-cancer drugs associated with febrile neutropenia with fever. Several bio-generic versions are now also available in markets such as Europe and Australia. Filgrastim (Neupogen) and PEG-filgrastim (Neulasta), or pegylated form of filgratim, are two commercially available forms of rhG-CSF. The pegylated form of filgratim form has a much longer half-life, reducing the necessity of daily injections. The FDA approved the first biosimilar of Neulasta in June 2018. It is made by Mylan and sold as Fulphila. Another form of rhG-CSF called lenograstim is synthesised in Chinese hamster ovary cells (CHO cells). As this is a mammalian cell expression system, lenograstim is indistinguishable from the 174-amino acid natural human G-CSF. No clinical or therapeutic consequences of the differences between filgrastim and lenograstim have yet been identified, but there are no formal comparative studies.
=== Diet === People with autoimmune hyperthyroidism (such as in Graves' disease) should not eat foods high in iodine, such as edible seaweed and seafood. From a public health perspective, the general introduction of iodized salt in the United States in 1924 resulted in lower rates of disease and goiters, and improved the lives of children whose mothers would not have eaten enough iodine during pregnancy, which would have lowered the IQs of their children.
Source: Tendon cells are typically elongated, spindle-shaped cells that align along the axis of tendon fibers. They contain large amounts of rough endoplasmic reticulum to support the production of collagen. The unique structure of tendon cells allows them to withstand mechanical stress and contribute to tendon strength and flexibility.
In 2023, it was the 246th most commonly prescribed medication in the United States, with more than 1 million prescriptions. It is available as a generic medication. In 2023, the combination of dexamethasone with neomycin and polymyxin B was the 260th most commonly prescribed medication in the United States, with more than 1 million prescriptions; and the combination of dexamethasone with ciprofloxacin was the 283rd most commonly prescribed medication in the United States, with more than 700,000 prescriptions;
congressman from New York George Izard* (1793), general, politician; second governor of the Territory of Arkansas James Parker (1793), U.S. congressman from New Jersey Peter A. Jay (1794), son of Chief Justice John Jay; member of New York State Assembly and Recorder of New York City Cyrus King (1794), U.S. congressman from Massachusetts John Ferguson (1795), mayor of New York City Daniel D. Tompkins (1795), vice president of the United States; governor of New York Rensselaer Westerlo (1795), U.S. congressman from New York Edward Philip Livingston (1796), member of the New York State Senate, great-great-grandfather of Eleanor Roosevelt Rudolph Bunner (1798), U.S. congressman from New York John M. Bowers (1800s), U.S. congressman from New York Gulian C. Verplanck (1801), U.S. congressman from New York and chairman of the United States House Committee on Ways and Means Gouverneur Kemble (1803), U.S. congressman from New York and founder of the West Point Foundry John L. Lawrence (1803), member of New York State Assembly and New York State Senate Alpheus Sherman (1803), member of New York State Senate James Alexander Hamilton (1805), son of Alexander Hamilton, soldier, acting United States secretary of state under president Andrew Jackson, and U.S. attorney for the Southern District of New York 1829–1834 Edmund H. Pendleton (1805), U.S. congressman from New York, great-nephew of Edmund Pendleton, first chief justice of Virginia Samuel B.
Sources: en.wikipedia.org
The Academy of Clinical Laboratory Physicians and Scientists is a learned society for scientists in the fields of clinical pathology and laboratory medicine. It was founded on November 12, 1966, in Bethesda, Maryland by a group of fifty-one individuals, led by David Seligson, Jon Straumfjord, George Z. Williams, Ernest Cotlove, and Ellis Benson. The society's founding mission was to represent scientists in the fields of clinical pathology and laboratory medicine in both the United States and Canada. As of 2015, it had 295 active members, as well as an additional 127 associate members, 195 emeritus members, and 5 honorary members. Along with the American Society for Clinical Pathology, it co-sponsors the American Journal of Clinical Pathology.
Propanephosphonic acid anhydride (PPAA, T3P, Allessan CAP) is the trimeric anhydride of n-propylphosphonic acid. It is a useful reagent for peptide synthesis reactions, where it activates the carboxylic acid partner for subsequent reaction with a primary or secondary amine. It is commercially available as 50% solution in DMF or ethyl acetate as a slightly yellow mixture. Examples of Propanephosphonic acid anhydride being used in the industrial syntheses of pharmaceuticals include the Pfizer synthesis of dacomitinib, the Neurosearch synthesis of SNDRIs such as PC44156003, the last step of the synthesis of selinexor, and the synthesis of darolutamide.
The basis of bone tissue engineering is that the materials will be resorbed and replaced over time by the body's own newly regenerated biological tissue. Tissue engineering is not only limited to the bone: a large amount of research is devoted to cartilage, ligament, skeletal muscle, skin, blood vessel, and neural tissue engineering as well.
== Production == Pyruvic acid is prepared by treating tartaric acid with acid. It can also be produced by oxidation of propylene glycol by potassium permanganate or bleach. The hydrolysis of acetyl cyanide, formed by reaction of acetyl chloride with potassium cyanide, represents yet another route:
Sources: en.wikipedia.org
The colour depends on copper held in a specific coordination environment. When the complex dissociates or the peptide is cleaved, that environment changes and the visible absorption weakens.
Frozen solutions are generally less stable than dry powder, and repeated thawing accelerates breakdown. Storage temperature, concentration and buffer composition all shift the rate, so no single figure applies to every preparation.
Chromatography separates and quantifies peptide species but does not report metal content. A separate elemental measurement is needed to show how much copper is present.
It is the copper(II) complex of the tripeptide glycyl-L-histidyl-lysine, a sequence of three amino acids. The copper ion is held by the histidine imidazole, the terminal amino group, and an amide nitrogen. The bound form is distinct from the free peptide in charge, color, and stability.